Chamber and committees

The following table shows the number of samples collected within the cervical screening programme from 1 January 2019 to 26 August 2021. As part of the response to the COVID-19 pandemic, the cervical screening programme was paused between 30 March 2020 and 29 June 2020. The table below shows that a small number of samples were collected during this time; this is because colposcopy and gynaecology continued taking samples for clinical management, and some GP practices continued screening for those on non-routine recall.

Screening resumed on 29 June 2020 in a phased, careful and prioritised way, as part of the remobilisation of the NHS in Scotland. Anyone who was invited for cervical screening before the pause in March and had yet to make an appointment or had it cancelled was able to make an appointment from 29 June 2020. Non-routine cervical screening appointments resumed in mid-July and routine screening appointments from September 2020.

It is important to note that the data below is management information and has not been subject to the necessary quality checks carried out for an official publication.

Waiting time statistics for patients requiring treatment related to MS is not held centrally by the Scottish Government or Public Health Scotland (PHS). Patients’ specific condition or diagnosis is not collected by the PHS Waiting Times Team.

In regards to improving early diagnosis and understanding symptoms, the Scottish Government has provided a total of £650,000 funding to the Future MS project led by the University of Edinburgh. Future MS involves the collection of clinical data and biological samples from recently diagnosed, treatment naïve, relapsing-onset multiple sclerosis patients in order to develop a more personalised approach to clinical management. The project has recruited more than 400 MS patients from across all the territorial NHS Boards in Scotland.

We will invest £4.5 million over 5 years to implement the 17 commitments of the Neurological Care and Support in Scotland: A Framework for Action 2020 – 2025 . The aims include improving the provision of co-ordinated health and social care and support, developing sustainable workforce models and ensuring high standards of person-centred care for those with neurological conditions, such as MS. Over £300,000 has been committed so far to projects which improve the health and wellbeing of people with MS in Scotland, via the Framework.

The Scottish Government maintains positive relationships with third sector partners such as the MS Society, the MS Trust and Revive MS Support, supporting them to complement services provided by NHS Boards and improve understanding of the early symptoms of MS.

The Scottish Government expects everyone to be treated with consideration, dignity and respect when accessing and using NHS services. NHS staff will make every effort to ensure that the privacy and dignity of all patients are maintained in Scottish hospitals.

All patients should routinely be cared for in wards or bays which are for single sex occupancy. The Scottish Government provided guidelines and recommendations on the elimination of mixed sex accommodation in 1999 and 2000. Further guidance and direction regarding the provision of clinically appropriate single room accommodation in all planned new buildings and major refurbishments was provided in 2008 and 2010.

The Scottish Government does not hold national data for infectious diseases screening, antenatal haemoglobinopathies screening, or foetal anomaly ultrasound examinations within the pregnancy screening programme. These can be requested directly from individual NHS boards.

The following table shows the number of trisomy screens taken between January 2019 and June 2021.

It is important to note that the data provided below is management information and has not been subject to the necessary quality checks carried out for an official publication.

As part of the NHS Scotland response to coronavirus (COVID-19), an Innovation Workstream has been created to manage the evaluation of antibody and swab (PCR) tests. This workstream is led by NHS NSS and clinical scientists from NHS Health Boards, and is designed to take advantage of rapid innovations within testing, while at the same time avoiding duplication of effort between Health Boards.

As part of this workstream, antibody tests being used within Scotland are validated by NHS Scotland. The evaluation reports for the antibody assays which have currently been validated and are in use are publicly available, and can be found on NHS Scotland’s Health Innovation Assessment Portal . These evaluation reports show the high sensitivity and specificity of antibody tests approved for use within Scotland.

Scotland is also part of the UK National Testing Programme, participating in UK-wide antibody studies such as the Post Positive PCR Antibody Testing Initiative, where antibody tests have been validated by the UK Government. These validation reports are publicly available, and can be found on the UK Government website .

The Scottish Government does not hold information on the newborn hearing test and newborn infant physical examination. These would need to be requested from health boards directly.

The following table shows the number of babies screened using the bloodspot test in the newborn screening programme between January 2019 and July 2021.

It is important to note that the data provided below is management information and has not been subject to the necessary quality checks carried out for an official publication.

I refer the member to the answer to question S6W-02419 on 21 September 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

I refer the member to the answer to question S6W-02419 on 21 September 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The following table shows the number of people screened for diabetic retinopathy in each month between January 2019 and July 2021. The Diabetic Eye Screening (DES) programme was paused between 30 March 2020 and 6 July 2020. When screening resumed, those at high risk of developing diabetic retinopathy were prioritised and invited first.

It is important to note that the following data is management information and has not been subject to the necessary quality checks carried out for an official publication.

The Scottish Government works closely with all stakeholders including Trade Unions, to deliver the vital communication messages across the Prison Estate and the Member will appreciate that staff as part of the wider community, can be vaccinated and it is not mandatory for staff to report their vaccination status, to their employer. The Scottish Prison Service (SPS) throughout the Prison Estate is effectively ensuring that we are progressing vaccinations against COVID-19 in conjunction with health professionals from Public Health Scotland (PHS), as well as other health agencies .

We realise that through our work with public health agencies in conjunction with SPS, that we have a job to engage with the prison population. In many ways it mirrors the issues found in wider society and we are dealing with the hardest to reach. Tailored communications are delivered to those in a prison setting. The National Clinical Director attended HMP Barlinnie for a Q&A session with prisoners which was made available via prison radio and TV. Posters with the same national ‘roll up your sleeves’ messaging and appropriate photography were distributed to prisons to be displayed.